CricPokChic Posted March 7, 2019 Report Share Posted March 7, 2019 anybody following? Quote Link to comment Share on other sites More sharing options...
Msdian Posted March 7, 2019 Report Share Posted March 7, 2019 antha mandi stocks manam enduku follow avutham baa missed it Quote Link to comment Share on other sites More sharing options...
CricPokChic Posted March 7, 2019 Author Report Share Posted March 7, 2019 $2 last week....$5 yesterday and going up since.......sky is the limit now.... Quote Link to comment Share on other sites More sharing options...
argadorn Posted March 7, 2019 Report Share Posted March 7, 2019 1 minute ago, CricPokChic said: $2 last week....$5 yesterday and going up since.......sky is the limit now.... apeyi akade akade .. uncle neeto edey problem iq 16 lo unappudu konukunavu 35 ayinappudu thread veshavu .... edhi kuda tahkuva lo cheppavu full rise ayyaka chepathaunavu ... Quote Link to comment Share on other sites More sharing options...
Msdian Posted March 7, 2019 Report Share Posted March 7, 2019 64.94 now Quote Link to comment Share on other sites More sharing options...
WigsandThighs Posted March 7, 2019 Report Share Posted March 7, 2019 WTF 🤭 Quote Link to comment Share on other sites More sharing options...
WigsandThighs Posted March 7, 2019 Report Share Posted March 7, 2019 Bus miss ayinadhi..addamaina buses yekki jeevitham sankanaaki poyindhi 🤦🏾♂️ Quote Link to comment Share on other sites More sharing options...
CricPokChic Posted March 7, 2019 Author Report Share Posted March 7, 2019 7 minutes ago, argadorn said: apeyi akade akade .. uncle neeto edey problem iq 16 lo unappudu konukunavu 35 ayinappudu thread veshavu .... edhi kuda tahkuva lo cheppavu full rise ayyaka chepathaunavu ... naku ippude telisindi bro BPTH gurunchi.....IQ first lo nenu confident lenu....anduke cheppaledu bro.... Quote Link to comment Share on other sites More sharing options...
MRI Posted March 7, 2019 Report Share Posted March 7, 2019 22 minutes ago, CricPokChic said: $2 last week....$5 yesterday and going up since.......sky is the limit now.... 15min back ee sky reach ayinattu vundi kada.. haha Quote Link to comment Share on other sites More sharing options...
Yaman02 Posted March 7, 2019 Report Share Posted March 7, 2019 wonderful!! Quote Link to comment Share on other sites More sharing options...
TensionNahiLeneka Posted March 7, 2019 Report Share Posted March 7, 2019 get ready for big dump. market cap 8 Mil anta, 9 employees anta. watch before you buy , lekapote lachal lachal potayi. some useful 14000 post. Quote Link to comment Share on other sites More sharing options...
megadheera Posted March 7, 2019 Report Share Posted March 7, 2019 Trading halted Quote Link to comment Share on other sites More sharing options...
CricPokChic Posted March 7, 2019 Author Report Share Posted March 7, 2019 9 minutes ago, TensionNahiLeneka said: get ready for big dump. market cap 8 Mil anta, 9 employees anta. watch before you buy , lekapote lachal lachal potayi. some useful 14000 post. ya dont buy now...already perigipoindi...and falling down now.....2-5$ unnapudu koni unte correct ga undedi Quote Link to comment Share on other sites More sharing options...
Yaman02 Posted March 7, 2019 Report Share Posted March 7, 2019 6 Top Gainers In Healthcare Sector (BPTH, OHRP, PRTO...) RTTNews Mar. 6, 2019, 07:53 PM (RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. Bio-Path Holdings Inc. (BPTH) Gained 160.46% to close Wednesday's (Mar.6) trading at $12.02. News: The clinical update to the previously reported interim analysis from Stage 1 of the Company's phase II trial of Prexigebersen for the treatment of acute myeloid leukemia reveals an improvement in efficacy profile and strong evidence of safety profile. The Stage 1 of the phase II study evaluated the efficacy and safety of Prexigebersen in conjunction with low dose cytarabine (LDAC), a therapeutic regimen well-established in the treatment of acute myeloid leukemia patients who cannot or elect not to be treated with more intensive chemotherapy. 2. OHR Pharmaceutical Inc. (OHRP) Gained 44.19% to close Wednesday's trading at $12.02. News: No news Recent events: -- On February 21, 2019, the Company announced it has regained compliance with the minimum bid price requirement under NASDAQ "Bid Price Rule. -- A 1-for-20 reverse stock split was effected on February 4, 2019. -- On January 3, 2019, Ohr announced a definitive merger agreement with NeuBase Therapeutics Inc. 3. Tenax Therapeutics Inc. (TENX) Gained 29.37% to close Wednesday's trading at $1.63. News: No news Clinical Trial: A phase II trial of Levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), dubbed H-E-L-P Trial, is underway. 4. Aytu BioScience Inc. (AYTU) Gained 29.09% to close Wednesday's trading at $1.42. News: The Company has entered into a licensing agreement with SUDA Pharmaceuticals Ltd (ASX:SUD) to distribute ZolpiMist outside the United States and Canada. ZolpiMist, an FDA-approved, prescription sleep aid indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation, was licensed by Aytu from Magna Pharmaceuticals, Inc. last July. Under the licensing agreement signed today, SUDA will pay Aytu a portion of each upfront and milestone payment received from sublicensees, and Aytu will receive ongoing royalty payments on sales generated by SUDA's sublicensees as ZolpiMist is launched in their territories. 5. Proteon Therapeutics Inc. (PRTO) Proteon is a late-stage biopharmaceutical company developing therapies to address some of the most urgent needs of hemodialysis and peripheral artery disease patients. Gained 21.48% to close Wednesday's trading at $3.62. News: No news Near-term Catalyst: Top-line data from the PATENCY-2 clinical trial are expected in March 2019. PATENCY-2 is a phase III study of its lead drug candidate Vonapanitase in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis. 6. Diffusion Pharmaceuticals Inc. (DFFN) Gained 18.16% to close Wednesday's trading at $4.49. News: No news Clinical Trials: The Company's lead drug candidate is Trans Sodium Crocinate. A phase III study of Trans Sodium Crocinate to target inoperable glioblastoma multiforme brain cancer, dubbed INTACT, is underway. The Company was given FDA clearance last September to conduct a phase II on-ambulance trial of Trans Sodium Crocinate for the treatment of stroke. Quote Link to comment Share on other sites More sharing options...
Quickgun_murugan Posted March 7, 2019 Report Share Posted March 7, 2019 15 minutes ago, TensionNahiLeneka said: get ready for big dump. market cap 8 Mil anta, 9 employees anta. watch before you buy , lekapote lachal lachal potayi. some useful 14000 post. Quote Link to comment Share on other sites More sharing options...
.thumb.gif.343fe49c7e1c507ae0056326bd8cf77e.gif)
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.